Sandbox kiran2: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 219: Line 219:
* [[Anticholinergic]]s, more specifically [[muscarinic antagonist]]s<ref>{{cite news|last=Patel|first=R.J.|author2=et al.|url=http://www.ncbi.nlm.nih.gov/m/pubmed/14751484/|title=Prevalence of autonomic signs and symptoms in antimuscarinic drug poisonings|journal=J. Emerg. Med.|date=Jan 2004|volume=26|number=1|pages=89–94}}</ref>
* [[Anticholinergic]]s, more specifically [[muscarinic antagonist]]s<ref>{{cite news|last=Patel|first=R.J.|author2=et al.|url=http://www.ncbi.nlm.nih.gov/m/pubmed/14751484/|title=Prevalence of autonomic signs and symptoms in antimuscarinic drug poisonings|journal=J. Emerg. Med.|date=Jan 2004|volume=26|number=1|pages=89–94}}</ref>


[[5-azacytidine ]],  
*[[5-azacytidine ]],  
[[Abacavir]],
*[[Abacavir]],
[[Amphetamines]],  
*[[Amphetamines]],  
[[Anticholinergics]],  
*[[Anticholinergics]],  
[[Asparaginase]],
*[[Asparaginase]],
[[Benztropine Mesylate]],   
*[[Benztropine Mesylate]],   
[[Bleomycin]],  
*[[Bleomycin]],  
*[[Bretylium|Bretylium tosylate]]
*[[Bretylium|Bretylium tosylate]]
[[Cocaine]],  
*[[Cocaine]],  
[[Cyclic antidepressant poisoning]],
*[[Cyclic antidepressant poisoning]],
[[Dabrafenib]],   
*[[Dabrafenib]],   
[[Didrex]],  
*[[Didrex]],  
[[Dimercaprol]],  
*[[Dimercaprol]],  
[[Dinoprostone]],  
*[[Dinoprostone]],  
*[[Tetanus, Diphtheria, and Pertussis (Tdap) Vaccine (patient information) |Diphtheria-pertussis-tetanus vaccine]],  
*[[Tetanus, Diphtheria, and Pertussis (Tdap) Vaccine (patient information) |Diphtheria-pertussis-tetanus vaccine]],  
[[Elotuzumab]],  
*[[Elotuzumab]],  
[[Elspar]],  
*[[Elspar]],  
[[Eribulin mesylate]],  
*[[Eribulin mesylate]],  
[[Ganciclovir]],  
*[[Ganciclovir]],  
[[Glycopyrrolate]],  
*[[Glycopyrrolate]],  
[[Imatinib mesylate]],
*[[Imatinib mesylate]],
[[Ioxilan]]
*[[Ioxilan]]
[[LSD]],
*[[LSD]],
[[MDMA]],  
*[[MDMA]],  
[[Methscopolamine bromide]],  
*[[Methscopolamine bromide]],  
[[Mepenzolate]],  
*[[Mepenzolate]],  
[[Micafungin]],  
*[[Micafungin]],  
[[MMR vaccine]],  
*[[MMR vaccine]],  
[[Monoamine oxidase inhibitors]],
*[[Monoamine oxidase inhibitors]],
[[Muscarinic antagonist]]s
*[[Muscarinic antagonist]]s
[[Oxaliplatin]],  
*[[Oxaliplatin]],  
[[Para-amino salicylic acid]],  
*[[Para-amino salicylic acid]],  
[[PCP]],  
*[[PCP]],  
[[Penicillamine]],
*[[Penicillamine]],
[[Propantheline bromide]],   
*[[Propantheline bromide]],   
[[Psychostimulant drugs]],  
*[[Psychostimulant drugs]],  
*[[Psychoactive drug|Psychotropic medications]]
*[[Psychoactive drug|Psychotropic medications]]
[[Pyrazinamide]],  
*[[Pyrazinamide]],  
[[Selective serotonin reuptake inhibitors]],  
*[[Selective serotonin reuptake inhibitors]],  
[[Serotonin syndrome]],  
*[[Serotonin syndrome]],  
[[Serotoninergic syndrome]],  
*[[Serotoninergic syndrome]],  
[[Succimer]],  
*[[Succimer]],  
[[Talimogene laherparepvec]],
*[[Talimogene laherparepvec]]
[[Tricyclic antidepressants]],  
*[[Tricyclic antidepressants]],  
[[Valganciclovir]],  
*[[Valganciclovir]],  
[[Withdrawal syndromes ]],
*[[Withdrawal syndromes ]],

Revision as of 21:05, 10 December 2016

Lsd, muscarinic antagonist,

  • Psychotropic medications
  • Psychostimulant drugs
  1. Tintinalli, Judith (2004). Emergency Medicine: A Comprehensive Study Guide, Sixth edition. McGraw-Hill Professional. p. 1818. ISBN 0-07-138875-3.
  2. Marx, John (2006). Rosen's emergency medicine: concepts and clinical practice. Mosby/Elsevier. p. 2894. ISBN 978-0-323-02845-5.
  3. Marx, John (2006). Rosen's emergency medicine: concepts and clinical practice. Mosby/Elsevier. p. 2388. ISBN 978-0-323-02845-5.
  4. Patel, R.J.; et al. (Jan 2004). "Prevalence of autonomic signs and symptoms in antimuscarinic drug poisonings". J. Emerg. Med. 26 (1). pp. 89–94.